Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Gossamer Bio
GOSS
$67.1M
| $769K | ﹤0.01% |
64,853
+32,898
| +103% | +$427K |
2025 Q4
3 quarters
|
|
2977
Niagen Bioscience
NAGE
$163M
| $768K | ﹤0.01% |
262,912
+139,858
| +114% | +$446K |
2025 Q3
4 quarters
|
|
2978
Barrett Business Services
BBSI
$737M
| $768K | ﹤0.01% |
25,369
+17,216
| +211% | +$609K |
2025 Q2
5 quarters
|
|
2979
Home Bancorp
HBCP
$482M
| $767K | ﹤0.01% |
11,617
+3,865
| +50% | +$269K |
2025 Q4
3 quarters
|
|
2980
PUT
Hims & Hers Health
HIMS
$4.62B
| $766K | ﹤0.01% |
25,700
+8,300
| +48% | +$255K |
2024 Q4
7 quarters
|
|
2981
Novo Nordisk
NVO
$184B
| $765K | ﹤0.01% |
20,188
-2,443
| -11% | -$113K |
2025 Q3
4 quarters
|
|
2982
Tsakos Energy Navigation Ltd
TEN
$1.43B
| $765K | ﹤0.01% |
16,196
-2,713
| -14% | -$115K |
2026 Q2
1 quarter
|
|
2983
PUT
Keysight
KEYS
$50.7B
| $764K | ﹤0.01% |
2,100
-15,900
| -88% | -$5.24M |
2025 Q4
3 quarters
|
|
2984
PUT
Parker-Hannifin
PH
$121B
| $764K | ﹤0.01% |
800
+200
| +33% | +$196K |
2023 Q3
12 quarters
|
|
2985
Solid Biosciences
SLDB
$763M
| $764K | ﹤0.01% |
+105,624
| New | +$956K |
2026 Q3
0 quarters
|
|
2986
CALL
Baker Hughes
BKR
$49.1B
| $763K | ﹤0.01% |
13,900
+5,800
| +72% | +$346K |
2026 Q2
1 quarter
|
|
2987
PUT
ZIM Integrated Shipping Services
ZIM
$3.54B
| $762K | ﹤0.01% |
26,000
-12,400
| -32% | -$334K |
2025 Q2
5 quarters
|
|
2988
Faeth Therapeutics
FTH
$259M
| $761K | ﹤0.01% |
+25,582
| New | +$796K |
2026 Q3
0 quarters
|
|
2989
CALL
CF Industries
CF
$18.3B
| $760K | ﹤0.01% |
6,600
-59,200
| -90% | -$7.29M |
2025 Q2
5 quarters
|
|
2990
Northwest Natural Holdings
NWN
$2.2B
| $760K | ﹤0.01% |
16,289
-9,882
| -38% | -$490K |
2026 Q1
2 quarters
|
|
2991
Wolfspeed
WOLF
$1.33B
| $759K | ﹤0.01% |
+26,972
| New | +$775K |
2026 Q3
0 quarters
|
|
2992
PUT
FirstEnergy
FE
$27.2B
| $758K | ﹤0.01% |
17,500
-268,500
| -94% | -$12.6M |
2026 Q1
2 quarters
|
|
2993
Mechanics Bancorp
MCHB
$3.19B
| $758K | ﹤0.01% |
51,275
-205,958
| -80% | -$3.3M |
2025 Q4
3 quarters
|
|
2994
NewMarket
NEU
$6.52B
| $758K | ﹤0.01% |
844
-3,139
| -79% | -$2.71M |
2026 Q1
2 quarters
|
|
2995
Ironwood Pharmaceuticals
IRWD
$800M
| $757K | ﹤0.01% |
190,626
+123,727
| +185% | +$517K |
2025 Q2
5 quarters
|
|
2996
Genuine Parts
GPC
$17B
| $757K | ﹤0.01% |
6,018
-564
| -9% | -$73.4K |
2017 Q4
35 quarters
|
|
2997
Zevra Therapeutics
ZVRA
$540M
| $756K | ﹤0.01% |
+68,932
| New | +$817K |
2026 Q3
0 quarters
|
|
2998
CALL
Dycom Industries
DY
$6.68B
| $753K | ﹤0.01% |
+2,800
| New | +$1.02M |
2026 Q3
0 quarters
|
|
2999
AEVEX Corp
AVEX
$866M
| $753K | ﹤0.01% |
+49,708
| New | +$863K |
2026 Q3
0 quarters
|
|
3000
Escalade
ESCA
$289M
| $752K | ﹤0.01% |
+39,534
| New | +$785K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.